周刊：马年投资锦囊|嘉实基金杨欢：“制造业优势+科技创新”的双轮驱动逻辑依然坚实，今年四大赛道蕴含机遇

Core Viewpoint - The dual-driven logic of "manufacturing advantages + technological innovation" remains solid, and current adjustments provide opportunities for long-term investment [1]. Group 1: Market Outlook for 2025 - The market in 2025 is divided into three phases: - The first phase from post-Spring Festival to April focuses on technology revaluation, driven by the international recognition of the DS model, with strong performances from Hong Kong internet giants and A-share tech companies [5]. - The second phase from May to September highlights accelerated AI capital expenditure and overseas expansion trends, with record-breaking collaborations in innovative drugs and enhanced competitiveness in the energy storage sector driving related stocks up [5]. - The third phase in the fourth quarter shifts towards expectations of PPI recovery due to "anti-involution" policies, benefiting cyclical sectors like chemicals [5]. - The non-ferrous metals industry is a consistent highlight throughout the year, with precious metals performing strongly in a weak dollar environment, leading to increases in industrial metals like copper and silver [5]. Group 2: Investment Opportunities for 2026 - Four key industrial tracks are identified for investment based on the "14th Five-Year Plan": - The AI industry remains central, with a focus on computing power investment as domestic internet companies are expected to significantly increase capital expenditure, benefiting the domestic computing power supply chain [6]. - The overseas expansion of the renewable energy sector, particularly in energy storage and electric vehicles, continues to be promising due to declining lithium battery costs and global energy transition demands [6]. - The commercial aerospace sector is entering an acceleration phase, supported by policy and industry resonance, with significant satellite reserves laid out for industry development [6]. - The internationalization of innovative drugs is progressing, with Chinese companies moving from licensing to direct overseas expansion, showcasing competitive R&D efficiency in large molecule drugs [6]. Group 3: Strategies for Market Volatility - Recent market volatility is attributed to rapid price increases raising demand concerns and emotional disturbances from uncertain events. A strategy of "not chasing high prices, focusing on valuation, and looking long-term" is recommended [7]. - For high-priced assets, careful evaluation of the potential for exceeding performance expectations is necessary, while solid companies with growth potential present opportunities during short-term adjustments [7]. - In managing product portfolios, dynamic adjustments are made through in-depth industry research, tracking changes in competitive landscapes, and timely adjustments to overvalued assets while focusing on undervalued companies with significant growth potential [7]. Group 4: Investment Strategy for the Year of the Horse - The overall market outlook for 2026 is optimistic, with the capital market remaining in a favorable environment. Continuous technological advancements and enhanced competitiveness in high-end manufacturing are expected to support corporate profitability and market stability [8]. - The market is anticipated to trend upward with fluctuations, necessitating a focus on rhythm and structural opportunities. Identifying certainty amid volatility through in-depth research and patient holding is expected to yield good returns [8].